SEC Filing Details
Document Details
Form
Filing Date
2026-01-14 11:20:12
Document Date
2026-01-14 11:20:12
Form Description
AMENDMENT NO. 2 TO SCHEDULE 13E-3
Filing Group
Current Reports
Company
Lakeshore Biopharma Co., Ltd.
Issuer
Lakeshore Biopharma Co., Ltd.